Status:
COMPLETED
Butorphanol in Pain Following Ablation for Hepatic Tumor
Lead Sponsor:
Bibo Wang
Collaborating Sponsors:
Eastern Hepatobiliary Surgery Hospital
Conditions:
Visceral Pain
Microwave Ablation
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
The objective of this investigation was to evaluate the influence of Butorphanol on postoperative pain mitigation in patients undergoing microwave ablation for hepatic tumor. Employing a rigorously de...
Eligibility Criteria
Inclusion
- patients performing Microwave Ablation sign the informed consent
Exclusion
- Patients with a body mass index \> 30 kg/m2 a history of depression opioid dependence poorly controlled hypertension (systolic blood pressure \> 180 mmHg) myocardial infarction severe liver disease significant abdominal pain before surgery patients with sensory system or language dysfunctions who could not cooperate to complete the scale pregnant women.
Key Trial Info
Start Date :
March 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 9 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06031129
Start Date
March 1 2023
End Date
August 9 2023
Last Update
September 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jinling Hosipiatl
Nanjing, Jiangsu, China, 200000